Ramosetron versus palonosetron in combination with aprepitant and dexamethasone for the control of highly emetogenic chemotherapy-induced nausea and vomiting

被引：0
|
作者：
Kwon, J. H. [1 ]
Kang, J-H. [2 ]
Lee, Y-G. [3 ]
Park, K. U. [4 ]
An, H. J. [5 ]
Sohn, J. [6 ]
Seol, Y. M. [7 ]
Lee, H. [8 ]
Yun, H-J. [9 ,10 ]
Ahn, J. S. [11 ]
Kim, H. J. [12 ]
机构：
[1] Hallym Univ, Kangdong Sacred Heart Hosp, Div Hematooncol, Dept Internal Med,Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Seoul ST Marys Hosp, Oncol, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Internal Med, Sch Med, Seoul, South Korea
[4] Keimyung Univ, Sch Med, Internal Med, Dongsan Med Ctr, Daegu, South Korea
[5] Catholic Univ Korea, St Vincents Hosp, Dept Med Oncol, Coll Med, Suwon, South Korea
[6] Yonsei Univ, Div Med Oncol, Dept Internal Med, Coll Med, Seoul, South Korea
[7] Pusan Natl Univ, Sch Med, Internal Med, Pusan Natl Univ Hosp, Busan, South Korea
[8] Ajou Univ, Sch Med, Hematol Oncol, Ajou Univ Hosp, Suwon, South Korea
[9] Chungnam Natl Univ, Sch Med, Daejeon, South Korea
[10] Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea
[11] Samsung Med Ctr, Hematol & Oncol, Seoul, South Korea
[12] ASAN Med Ctr, Clin Epidemiol & Biostat, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1705P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Multicenter nonrandomized trial of ramosetron versus palonosetron in controlling chemotherapy-induced nausea and vomiting for colorectal cancer
    Kim, Jin Soo
    Kim, Ji Yeon
    Lee, Sang-Jeon
    Park, Dong Kook
    Namgung, Hwan
    Kim, Chang Nam
    Choi, Won Jun
    Baek, Moo Jun
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2014, 87 (01) : 9 - 13
  • [22] Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy.
    Miya, Toshimichi
    Kobayashi, Kunihiko
    Hino, Mitsunori
    Ando, Masahiro
    Takeuchi, Susumu
    Seike, Masahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
  • [23] Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting
    Nakade, Susumu
    Ohno, Tomoya
    Kitagawa, Junsaku
    Hashimoto, Yoshitaka
    Katayama, Masahiro
    Awata, Hiroshi
    Kodama, Yasuo
    Miyata, Yasuyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 75 - 83
  • [24] Cost-effectiveness of palonosetron and dexamethasone-based triple and quadruple regimens in preventing highly emetogenic chemotherapy-induced nausea and vomiting
    Halloush, Shiraz
    Alhifany, Abdullah A.
    Alkhatib, Nimer S.
    Al Bawab, Abdel Qader
    AL-Qawasmeh, Batool
    Al Shawakri, Esra'a
    Koeller, Jim
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (04) : 571 - 577
  • [25] Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting
    Susumu Nakade
    Tomoya Ohno
    Junsaku Kitagawa
    Yoshitaka Hashimoto
    Masahiro Katayama
    Hiroshi Awata
    Yasuo Kodama
    Yasuyuki Miyata
    Cancer Chemotherapy and Pharmacology, 2008, 63 : 75 - 83
  • [26] Palonosetron versus ondansetron in CINV (chemotherapy-induced nausea and vomiting)
    Vieira, S.
    Monroe, D.
    Sorita, R.
    Palomar, M.
    Librojo, M.
    Porin, L.
    Ng, J.
    Taylor, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S370 - S370
  • [27] Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin
    Choi, Chel Hun
    Kim, Min Kyu
    Park, Jin-Young
    Yoon, Aera
    Kim, Ha-Jeong
    Lee, Yoo-Young
    Kim, Tae-Joong
    Lee, Jeong-Won
    Kim, Byoung-Gie
    Bae, Duk-Soo
    SUPPORTIVE CARE IN CANCER, 2014, 22 (05) : 1181 - 1187
  • [28] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Takako Inoue
    Madoka Kimura
    Junji Uchida
    Kazumi Nishino
    Toru Kumagai
    Junko Taniguchi
    Fumio Imamura
    International Journal of Clinical Oncology, 2017, 22 : 600 - 604
  • [29] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Inoue, Takako
    Kimura, Madoka
    Uchida, Junji
    Nishino, Kazumi
    Kumagai, Toru
    Taniguchi, Junko
    Imamura, Fumio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) : 600 - 604
  • [30] A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy
    Takahashi, Tsutomu
    Okada, Takahiro
    Ikejiri, Fumiyoshi
    Ito, Shunsuke
    Okada, Yusuke
    Takahashi, Fumimasa
    Kumanomido, Satoshi
    Jo, Yumi
    Adachi, Koji
    Onishi, Chie
    Kawakami, Koshi
    Miyake, Takaaki
    Inoue, Masaya
    Suzuki, Ritsuro
    Suzumiya, Junji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 189 - 194
12345